Edinburgh Business School

Proton Capital Enters Into Agreement to Purchase PharmaChoice Canada Branded Pharmacy In Saskatoon For Proposed Qualifying Transaction

Retrieved on: 
Thursday, February 22, 2024

The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.

Key Points: 
  • The Share Purchase Agreement provides that Proton will purchase 75% of the issued and outstanding shares of the Target Pharmacy.
  • The Qualifying Transaction will not constitute a Non-Arm’s Length Qualifying Transaction (as such term is ‎defined in the policies of the TSXV).
  • The parties to the Qualifying Transaction are at arm’s length and therefore the approval of the shareholders of ‎Proton in respect of the Qualifying Transaction will not be required.
  • The Prospectus will contain important detailed information about the Corporation, the Qualifying ‎Transaction and the proposed Offering.

Global Wellness Summit Announces Finalists for the 8th Annual "Shark Tank of Wellness" Student Competition

Retrieved on: 
Wednesday, September 27, 2023

MIAMI, Sept. 27, 2023 /PRNewswire-PRWeb/ -- The Global Wellness Summit (GWS), the most prestigious conference on the $4.4 trillion business of wellness, is pleased to announce the three student finalists selected to present their wellness business concepts to a panel of "Wellness Sharks" at the 2023 GWS in Doha, Qatar, November 6-9. The finalists were chosen in a blind judging of the over 350 entries from 22 countries.

Key Points: 
  • The 'Shark Tank of Wellness' is an incredible opportunity for these young entrepreneurs to gain recognition, funding, and invaluable industry insights.
  • We look forward to seeing their ideas come to life and inspire the future of wellness.
  • "The Shark Tank of Wellness provides an exceptional opportunity for aspiring young innovators with new and groundbreaking wellness business ideas.
  • The 'Shark Tank of Wellness' is an incredible opportunity for these young entrepreneurs to gain recognition, funding, and invaluable industry insights.

Billups Appoints Former Yahoo Executive Stephanie Gutnik as Global Chief Strategy Officer

Retrieved on: 
Wednesday, September 13, 2023

Billups , a global Out-of-Home (OOH) technology and managed services company, today announced the appointment of Stephanie Gutnik as global chief strategy officer.

Key Points: 
  • Billups , a global Out-of-Home (OOH) technology and managed services company, today announced the appointment of Stephanie Gutnik as global chief strategy officer.
  • “With 20 years of unparalleled OOH expertise and innovation, Billups is the gold standard for OOH planning, activation, and measurement.
  • She also previously ran marketing for Broadsign and worked in advertising sales at News Corp.
    "Stephanie's appointment to our leadership team marks a pivotal moment in Billups' journey,” said Billups chief executive officer David Krupp.
  • Together, Krupp, Gutnik and the global team at Billups aim to redefine the boundaries of OOH advertising, blending innovation with strategic, data-backed insights to drive unparalleled growth and engagement in the industry.

Petro Victory Energy Corp Announces Appointment of New Chief Operating Officer

Retrieved on: 
Tuesday, July 11, 2023

CALGARY, AB, July 11, 2023 /PRNewswire/ - Petro-Victory Energy Corp. (TSXV: VRY) is delighted to announce the appointment of Mr. Andre Naslausky as Chief Operating Officer.

Key Points: 
  • CALGARY, AB, July 11, 2023 /PRNewswire/ - Petro-Victory Energy Corp. (TSXV: VRY) is delighted to announce the appointment of Mr. Andre Naslausky as Chief Operating Officer.
  • Additionally, Mr. Naslausky led efforts to enhance production operations and facilities, streamline E&P projects, and maximize productivity and capacity.
  • "I am very pleased to announce Andre as our new Chief Operating Officer.
  • We also express our gratitude to Richard Lane for his instrumental role in establishing Petro Victory Energy as a leading onshore player in Brazil.

Sopheon Adds Former Ideagen Executive Barnaby Kent to Its Board of Directors

Retrieved on: 
Monday, February 6, 2023

PITTSBURGH, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sopheon, the global leader in Innovation Management software and expertise, announced the addition of Barnaby (Barney) Kent as a non-executive member of Sopheon’s Board of Directors.

Key Points: 
  • PITTSBURGH, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Sopheon, the global leader in Innovation Management software and expertise, announced the addition of Barnaby (Barney) Kent as a non-executive member of Sopheon’s Board of Directors.
  • Kent becomes the seventh Sopheon Board member and the fourth non-executive member.
  • “Barney Kent’s addition to the Board further positions Sopheon to execute its mission to empower organizations to change the world,” said Greg Coticchia, chief executive officer of Sopheon.
  • “Joining the Sopheon Board represents an exciting opportunity to assist an already thriving organization to maximize its value,” said Kent.

$428 million advisor team joins UBS in Hartford, Connecticut

Retrieved on: 
Friday, September 30, 2022

UBS Wealth Management USA today announced that Matthew Tashjian and Jason Farkas have joined the firm as Financial Advisors in Hartford, Connecticut.

Key Points: 
  • UBS Wealth Management USA today announced that Matthew Tashjian and Jason Farkas have joined the firm as Financial Advisors in Hartford, Connecticut.
  • The team is responsible for managing a combined $428 million in client assets for high net worth individuals and families.
  • They bring more than 50 years of combined experience to UBS, and will be invaluable as we continue to expand our client offering in the Connecticut area and beyond.
  • The key symbol and UBS are among the registered and unregistered trademarks of UBS.

SOTIO Bolsters Leadership Team with Appointment of Martin Steegmaier as Chief Scientific Officer

Retrieved on: 
Wednesday, September 14, 2022

PRAGUE, Czech Republic, Sept. 14, 2022 (GLOBE NEWSWIRE) -- SOTIO Biotech , a clinical stage immuno-oncology company owned by PPF Group, announced the appointment of Martin Steegmaier, Ph.D., MBA, as chief scientific officer.

Key Points: 
  • PRAGUE, Czech Republic, Sept. 14, 2022 (GLOBE NEWSWIRE) -- SOTIO Biotech , a clinical stage immuno-oncology company owned by PPF Group, announced the appointment of Martin Steegmaier, Ph.D., MBA, as chief scientific officer.
  • Martin Steegmaier brings over 20 years of experience in oncology drug discovery, drug development and business development.
  • His extensive knowledge of the biotech industry and clinical immuno-oncology will be crucial as SOTIO continues to advance multiple assets through the clinic.
  • As a seasoned biotechnology industry veteran and oncology drug discovery and development expert, Dr. Steegmaier will be an invaluable member of SOTIOs leadership team as we work to develop new, innovative treatments for cancer patients, said Radek Spisek, chief executive officer of SOTIO.

Cembra appoints two new Members of the Management Board

Retrieved on: 
Wednesday, July 6, 2022

Zurich Alona Eiduka as Chief Operating Officer and Eric Anliker as General Counsel have been newly appointed to the Management Board of Cembra.

Key Points: 
  • Zurich Alona Eiduka as Chief Operating Officer and Eric Anliker as General Counsel have been newly appointed to the Management Board of Cembra.
  • Alona Eiduka took over the role of Chief Operating Officer and Member of the Management Board at Cembra on 1 July 2022.
  • Eric Anliker will become General Counsel at Cembra and a Member of the Management Board as of 1 September 2022.
  • "I am delighted to welcome Alona Eiduka and Eric Anliker to the Management Board.

MIKAEL NÄSSTRÖM APPOINTED VICE PRESIDENT, COMMERCIAL EXCELLENCE

Retrieved on: 
Monday, May 9, 2022

BERWYN, Pa., May 9, 2022 /PRNewswire/ -- AMETEK, Inc.(NYSE: AME) today announced the appointment of Mikael Nsstrm as Vice President, Commercial Excellence.

Key Points: 
  • BERWYN, Pa., May 9, 2022 /PRNewswire/ -- AMETEK, Inc.(NYSE: AME) today announced the appointment of Mikael Nsstrm as Vice President, Commercial Excellence.
  • In this newly created role, Mr. Nsstrm will help drive accelerated sales for AMETEK by leading company-wide commercial excellence initiatives and managing global corporate marketing.
  • Adept at developing and implementing commercial continuous improvement programs, Mr. Nsstrm will also be responsible for expanding AMETEK's digital marketing efforts on a global scale.
  • Mr. Nsstrm joined AMETEK in 2014 as Divisional Vice President, Europe, Middle East & India Marketing, and Managing Director, UK & Nordics, and most recently served as Divisional Vice President, Commercial Excellence and Marketing at AMETEK International.

ObsEva Annual General Meeting 2022

Retrieved on: 
Thursday, April 7, 2022

53 LR of the SIX Swiss Exchange

Key Points: 
  • 53 LR of the SIX Swiss Exchange
    Geneva, SwitzerlandandBoston, MA April 7, 2022 ObsEva SA(NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, today published the invitation to its 2022 Annual General Meeting of Shareholders to be held onMay 18, 2022at16:30 CESTat the company's offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228Plan-les-Ouates, Switzerland.
  • The agenda of the meeting will be as follows:
    1 Approval of the Annual Report, the Statutory Financial Statements and the Consolidated Financial Statements for Fiscal Year 2021
    The Board of Directors proposes that the annual report, the statutory financial statements and the consolidated financial statements of ObsEva SA for fiscal year 2021 be approved.
  • The Board of Directors proposes that the shareholders approve a maximum aggregate amount of compensation of USD 2,500,000 for the members of the Board of Directors for the period from the 2022 Annual General Meeting to the 2023 Annual General Meeting.
  • The full invitation to the AGM 2022 may be found in the general meetings section of the Company's website, [ here ].